There is a dire need to streamline operations in food, pharma, and cannabis. 23% of the world’s annual food production is lost due to poor logistics, food safety, and lack of training. Current logistics solutions are challenging to implement due to poor software compatibility and high integration costs— this is a sector that desperately needs […]
Category: Uncategorized
Bargain Hunting: Here’s 3 Stocks Ready to Make Waves in the Cannabis Business Right Now
The marijuana industry is growing like no other North America. ArcvView which tracks the sales is suggesting that legal weed could grow by 26% on an annual basis between 2016 and 2021. That puts the business at nearly $22 billion in annual sales. Even with regulatory restrictions, there’s presumably a lot of money to made, […]
Protected: Industry’s Lowest-Cost Micro EVs Standing Tall Among Auto Giants
There is no excerpt because this is a protected post.
Recession risk is ‘below average’ for the next three years, Goldman says
The U.S. economic expansion is probably only in its middle stages, with the chances of a recession in the next three years at a “below average” possibility, according to Goldman Sachs. Though the current run is just 10 months away from being the longest expansion on record, Goldman economist Daan Struyven used a model to […]
Analyst Review: Lithium, What Is It’s Uses And Why Has It Exploded In Popularity
The lightest known metal can also lighten your mood. Lithium, atomic number 3, is an element of many uses. It’s used in aircraft manufacture and in certain batteries. It’s also used in mental health: Lithium carbonate is a common treatment of bipolar disorder, helping to stabilize the wild mood swings caused by the illness. Lithium […]
Biotech stocks are breaking out and getting ready to dominate
Now that September is here, it’s back to business as usual, especially on Wall Street. But something to chew on over the next few days is just how well the biotech sector has done. That sector rallied all last week, which helped to drive the Nasdaq to its first record close since July. The iShares Nasdaq Biotech […]
Is This Biotech Play the Next Big Thing?
Innovation, cutting-edge drug technology, clinical expertise, access to capital … all point to repeated FDA approvals, accelerated revenue growth and a winning addition to your portfolio. Here at The Money Street, we have discovered a gem of a Company … a burgeoning biotechnology development company, which has already built a strong AND growing portfolio of […]